FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus - HUBER, LENA; BIRK, RICHARD; KNUETTEL, MANUEL; ROTTER, NICOLE; ADERHOLD, CHRISTOPH; SCHERL, CLAUDIA; LAMMERT, ANNE; JUNGBAUER, FREDERIC; KRAMER, BENEDIKT (Anticancer research, 2020)
Keywords: Cancer; Cancer therapies; Cell growth; Cell proliferation; Chemotherapy; Enzyme-linked immunosorbent assay; Experiments; Fibroblast growth factor 1; Fibroblast growth factor 2; Fibroblast growth factors; Gefitinib; Growth factors; Head and neck carcinoma; Human papillomavirus; Inhibitors; Kinases; Leukemia; Ligands; Medical prognosis; Metabolism; Metastasis; Peptides; Proteins; Rapamycin; Squamous cell carcinoma; Statistical analysis; TOR protein; Tumor cell lines; Tumorigenesis; Tyrosine; Tyrosine kinase inhibitors; United States--US; Germany